Vertex Pharmaceuticals Incorporated Outlines Corporate Strategy and Defines Key 2013 Business Priorities
SAN FRANCISCO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today outlined the company’s strategy and defined key 2013 business priorities to support continued growth and the creation of long-term shareholder value. Vertex’s Chairman, President and Chief Executive Officer, Jeffrey Leiden, M.D., Ph.D., will discuss the company’s strategy and 2013 priorities as part of a live presentation at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7 at 10:00 a.m. PT (1:00 p.m. ET). The presentation will be webcast on Vertex’s website, www.vrtx.com.